B+
Bull case
20%
Probability
Target price
$3.10
Analysis reference price unavailable
Analysis 2026-08-13 · RankAlpha Sentiment Codex
TXMD
TherapeuticsMDBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive royalty income and $9.2 million of cash provide some support, while a strategic transaction could create substantial upside; however, the company offers no timetable or assurance for such an outcome [#SEC-8K-2026-08-11].
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
Dependence on licensees and their product sales for royalty revenue.
Momentum
86
Value
53
Sentiment
54
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.80 · Bull $3.10 · Bear $0.90Analysis 2026-08-13; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-27 • Vendor: Data Vendor v1
Scores
As of 2026-10-26 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-13 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-26
Investment thesis
As of 2026-10-26
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-26. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Why
Momentum86 · Δ7d -
Value53 · Δ7d -0.0
Sentiment54 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • Dependence on licensees and their product sales for royalty revenue.
- • Going-concern, Nasdaq-listing, litigation, and liquidity risks remain relevant.
- • Q2 license revenue and net income declined year over year, expenses increased modestly, and the company remains dependent on licensee performance, dispute resolution, and strategic-alternative execution.
Catalyst clock
2026-08-11
Q2 2026 results were mixed
Lead driver: Value · See fundamentals
Momentum
86
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
53
47% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.3
Sentiment
54
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 85.8 / Value 53.4 / Sentiment 54.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-13. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$1.80
Analysis reference price unavailable
Analysis 2026-08-13 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.90
Analysis reference price unavailable
Analysis 2026-08-13 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-27
Fundamentals (TTM)
As of 2026-10-27
Market Cap
$20.6M
Beta
0.51
Shares Out
11.57M
P/E (TTM)
288.5
P/S (TTM)
7.45
P/FCF (TTM)
10.07
Rev YoY
-8.7%
EPS YoY
-72.1%
Gross Margin
+49.4%
Op Margin
-117.8%
Net Debt
-$1.39M
Current Ratio
2.76
As of 2026-10-26 • Updated nightlySource: Internal modelMethods & Data